SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-22-241939
Filing Date
2022-09-09
Accepted
2022-09-09 16:05:48
Documents
13
Effectiveness Date
2022-09-09

Document Format Files

Seq Description Document Type Size
1 S-3ASR d347132ds3asr.htm S-3ASR 351347
2 EX-1.2 d347132dex12.htm EX-1.2 186066
3 EX-4.3 d347132dex43.htm EX-4.3 307273
4 EX-5.1 d347132dex51.htm EX-5.1 29442
5 EX-5.2 d347132dex52.htm EX-5.2 5795
6 EX-23.1 d347132dex231.htm EX-23.1 1276
7 EX-FILING FEES d347132dexfilingfees.htm EX-FILING FEES 53458
8 GRAPHIC g347132dsp098.jpg GRAPHIC 6855
9 GRAPHIC g347132dsp104.jpg GRAPHIC 7186
10 GRAPHIC g347132dsp104a.jpg GRAPHIC 9804
11 GRAPHIC g347132dsp99a.jpg GRAPHIC 2872
12 GRAPHIC g347132g00a04.jpg GRAPHIC 55640
13 GRAPHIC g347132g00a30.jpg GRAPHIC 54214
  Complete submission text file 0001193125-22-241939.txt   1125008
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-267351 | Film No.: 221236096
SIC: 8071 Services-Medical Laboratories